Article Abstract

Is “watch and wait” a viable option for surgically resected brain metastases?

Authors: John Kang, Michael T. Milano

Abstract

A Phase III Japan Clinical Oncology Group (JCOG) trial, by Kayama et al., randomized patients with ≤4 brain metastases (single brain metastasis in 73%), who underwent resection of at least one brain metastasis, to adjuvant whole brain radiotherapy (WBRT) or salvage stereotactic radiosurgery (SRS) (1).